Lars Iversen (L Iversen)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 29

Top Venues

EMBO molecular medicine

The British journal of dermatology

International journal of molecular sciences

Life science alliance

Aarhus Universitet Health

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aarhus Universitet Health

Denmark

Professor :: Dept of Dermatology

Publications

Thomas Emmanuel, Borislav Ignatov, Trine Bertelsen, Thomas Litman, Morten Muhlig Nielsen, Mikkel Bo Brent, Toke Touborg, Anders Benjamin Rønsholdt, Annita Petersen, Mette Boye, Ida Kaaber, Daniel Sortebech, Dorte Lybæk, Torben Steiniche, Anne Bregnhøj, Liv Eidsmo, Lars Iversen, Claus Johansen
Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease Memory. International journal of molecular sciences 25 (11) (2024)
Sailan Wang, Pernilla Nikamo, Leena Laasonen, Bjorn Gudbjornsson, Leif Ejstrup, Lars Iversen, Ulla Lindqvist, Jessica J Alm, Jesper Eisfeldt, Xiaowei Zheng, Sergiu-Bogdan Catrina, Fulya Taylan, Raquel Vaz, Mona Ståhle, Isabel Tapia-Paez
Rare coding variants in NOX4 link high ROS levels to psoriatic arthritis mutilans. EMBO molecular medicine (2024)
Sailan Wang, Pernilla Nikamo, Leena Laasonen, Bjorn Gudbjornsson, Leif Ejstrup, Lars Iversen, Ulla Lindqvist, Jessica J Alm, Jesper Eisfeldt, Xiaowei Zheng, Sergiu-Bogdan Catrina, Fulya Taylan, Raquel Vaz, Mona Ståhle, Isabel Tapia-Paez
Rare coding variants in NOX4 link high ROS levels to psoriatic arthritis mutilans. EMBO molecular medicine 16 (3) (2024)
Mette Gyldenløve, Jennifer Astrup Sørensen, Simon Francis Thomsen, Simon Fage, Lars Iversen, Lone Skov, Claus Zachariae, Alexander Egeberg, Mia-Louise Nielsen
Improvements in patient-reported outcomes with oral roflumilast for psoriasis: Results from a randomized controlled trial (PSORRO). Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Sailan Wang, Pernilla Nikamo, Leena Laasonen, Bjorn Gudbjornsson, Leif Ejstrup, Lars Iversen, Ulla Lindqvist, Jessica J Alm, Jesper Eisfeldt, Xiaowei Zheng, Sergiu-Bogdan Catrina, Fulya Taylan, Raquel Vaz, Mona Ståhle, Isabel Tapia-Paez
Rare coding variants in NOX4 link high ROS levels to psoriatic arthritis mutilans. EMBO molecular medicine 16 (3) (2024)
Kasper Fjellhaugen Hjuler, Louise Faurskov Møller, Cathrine Dawn Büttner Elgaard, Laura Gaïni, Lars Iversen, Tirill Fjellhaugen Hjuler
On the Interdisciplinary Treatment and Management of Patients with Immune-Mediated Inflammatory Diseases. A Study on Patients' Personal Experiences and Perspectives. Journal of multidisciplinary healthcare 17 (2024)
Kasper Fjellhaugen Hjuler, Louise Faurskov Møller, Cathrine Dawn Büttner Elgaard, Laura Gaïni, Lars Iversen, Tirill Fjellhaugen Hjuler
On the Interdisciplinary Treatment and Management of Patients with Immune-Mediated Inflammatory Diseases. A Study on Patients' Personal Experiences and Perspectives. Journal of multidisciplinary healthcare 17 (2024)
Sailan Wang, Pernilla Nikamo, Leena Laasonen, Bjorn Gudbjornsson, Leif Ejstrup, Lars Iversen, Ulla Lindqvist, Jessica J Alm, Jesper Eisfeldt, Xiaowei Zheng, Sergiu-Bogdan Catrina, Fulya Taylan, Raquel Vaz, Mona Ståhle, Isabel Tapia-Paez
Rare coding variants in NOX4 link high ROS levels to psoriatic arthritis mutilans. EMBO molecular medicine 16 (3) (2024)
Thomas Emmanuel, Borislav Ignatov, Trine Bertelsen, Thomas Litman, Morten Muhlig Nielsen, Mikkel Bo Brent, Toke Touborg, Anders Benjamin Rønsholdt, Annita Petersen, Mette Boye, Ida Kaaber, Daniel Sortebech, Dorte Lybæk, Torben Steiniche, Anne Bregnhøj, Liv Eidsmo, Lars Iversen, Claus Johansen
Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease Memory. International journal of molecular sciences 25 (11) (2024)
Sailan Wang, Pernilla Nikamo, Leena Laasonen, Bjorn Gudbjornsson, Leif Ejstrup, Lars Iversen, Ulla Lindqvist, Jessica J Alm, Jesper Eisfeldt, Xiaowei Zheng, Sergiu-Bogdan Catrina, Fulya Taylan, Raquel Vaz, Mona Ståhle, Isabel Tapia-Paez
Rare coding variants in NOX4 link high ROS levels to psoriatic arthritis mutilans. EMBO molecular medicine 16 (3) (2024)
Marlene Uglebjerg Fruergaard, Christine Juul Fælled Nielsen, Cecilia Rosada Kjeldsen, Lars Iversen, Jacob Lauwring Andersen, Poul Nissen
Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases. Life science alliance 6 (5) (2023)
Marlene Uglebjerg Fruergaard, Christine Juul Fælled Nielsen, Cecilia Rosada Kjeldsen, Lars Iversen, Jacob Lauwring Andersen, Poul Nissen
Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases. Life science alliance 6 (5) (2023)
Tiago Torres, Jordi Galván, Nigel Crutchley, Morten Praestegaard, Lars Iversen, Paolo Gisondi, Y José Manuel Carrascosa, Bruno Halioua, Anthony Bewley, Andreas Pinter
Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review. Dermatology and therapy (2023)
Hakim Ben Abdallah, Anne Bregnhøj, Lars Iversen, Claus Johansen
Transcriptomic Analysis of Hidradenitis Suppurativa: A Unique Molecular Signature with Broad Immune Activation. International journal of molecular sciences 24 (23) (2023)
Marlene Uglebjerg Fruergaard, Christine Juul Fælled Nielsen, Cecilia Rosada Kjeldsen, Lars Iversen, Jacob Lauwring Andersen, Poul Nissen
Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases. Life science alliance 6 (5) (2023)
Cathrine Dawn Büttner Elgaard, Lars Iversen, Kasper Fjellhaugen Hjuler
Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic Arthritis. Drugs in R&D (2023)
Christine Daugaard, Lars Iversen, Kasper Fjellhaugen Hjuler
Comorbidity in Adult Psoriasis: Considerations for the Clinician. Psoriasis (Auckland, N.Z.) 12 (2022)
Cathrine Dawn Büttner Elgaard, Lars Iversen, Kasper Fjellhaugen Hjuler
Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritis. The Journal of dermatological treatment (2022)
Thomas Emmanuel, Annita Petersen, Hannah Inez Houborg, Anders Benjamin Rønsholdt, Dorte Lybaek, Torben Steiniche, Anne Bregnhøj, Lars Iversen, Claus Johansen
Climatotherapy at the Dead Sea for psoriasis is a highly effective anti-inflammatory treatment in the short term: An immunohistochemical study. Experimental dermatology 31 (8) (2022)
Trine Bertelsen, Lars Iversen, Claus Johansen
I-Kappa-B-Zeta Regulates Interleukin-17A/Tumor Necrosis Factor-Alpha Mediated Synergistic Induction of Interleukin-19 and Interleukin-20 in Humane Keratinocytes. Annals of dermatology 33 (2) (2021)
Hakim Ben Abdallah, Claus Johansen, Lars Iversen
Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics. Psoriasis (Auckland, N.Z.) 11 (2021)
A Bregnhøj, K K H Thuesen, T Emmanuel, T Litman, C L Grek, G S Ghatnekar, C Johansen, Lars Iversen
HSP90 inhibitor RGRN-305 for oral treatment of plaque type psoriasis: efficacy, safety and biomarker results in an open-label proof-of-concept study. The British journal of dermatology (2021)
S K Mahil, Zenas Zee Ngai Yiu, Kayleigh J Mason, N Dand, B Coker, D Wall, G Fletcher, A Bosma, Francesca Capon, Lars Iversen, S M Langan, P Di Meglio, A H Musters, D Prieto-Merino, T Tsakok, R B Warren, Carsten Flohr, P I Spuls, C E M Griffiths, J Barker, Alan D Irvine, C H Smith, null null
Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic. The British journal of dermatology 183 (2) (2020)
Kirsten Rønholt, Ane Langkilde-Lauesen Nielsen, Claus Johansen, Christian Vestergaard, Astrid Fauerbye, Rubén López-Vales, Charles A Dinarello, Lars Iversen
IL-37 Expression Is Downregulated in Lesional Psoriasis Skin. ImmunoHorizons 4 (11) (2020)
K Reich, R B Warren, Lars Iversen, L Puig, I Pau-Charles, A Igarashi, M Ohtsuki, M Falqués, M Harmut, S Rozzo, M G Lebwohl, W Cantrell, Andrew Blauvelt, D Thaçi
Long-term efficacy and safety of tildrakizumab for moderate-to-severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks. The British journal of dermatology 182 (3) (2019)
Kasper Fjellhaugen Hjuler, Lars Iversen, M K Rasmussen, K Kofoed, L Skov, C Zachariae
Localization of treatment-resistant areas in patients with psoriasis on biologics. The British journal of dermatology 181 (2) (2019)
Kenneth Thomsen, Lars Iversen, Therese Louise Titlestad, Ole Winther
Systematic review of machine learning for diagnosis and prognosis in dermatology. The Journal of dermatological treatment 31 (5) (2019)
A Duvetorp, M Østergaard, L Skov, O Seifert, K S Tveit, K Danielsen, Lars Iversen
Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP). Archives of dermatological research 311 (5) (2019)
Lise Maria Lindahl, Søren Besenbacher, Anne H Rittig, Pamela Celis, Andreas Willerslev-Olsen, Lise M R Gjerdrum, Thorbjørn Krejsgaard, Claus Johansen, Thomas Litman, Anders Woetmann, Niels Odum, Lars Iversen
Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study. Blood 131 (7) (2017)

Lars Iversen.css-eqlu8i{font-size:small;padding-left:4px;} (L Iversen)

Publication Activity (10 Years)

Top Topics

Top Venues

Lars Iversen (L Iversen)